Related Funds
Fund Name | Location |
Acquipharma | - |
Brocade Communications Systems | California, San Jose, United States |
Canadian Government | Canada, Ontario, Ottawa |
Clinton Global Initiative | New York, New York, United States |
Crystal Internet Venture Funds | Cleveland, Ohio, United States |
Cycad Group | California, Santa Barbara, United States |
Dahua Technology | Binjiang, China, Jiangxi |
FINTECH VENTURES | Community of Madrid, Madrid, Spain |
GMV Innovative Solutions | Balearic Islands, Islas Baleares, Spain |
Maker Institute CAS | China, Guangdong, Tianjin |
Micromanagement Ventures | New York, New York, United States |
PolyTechnos Venture Partners | Bayern, Germany, Munich |
RATNAAFIN | Ahmedabad, Gujarat, India |
Ruixin Asset Management | Beijing, Beijing, China |
Technology Venture Partners | Bristol, England, United Kingdom |
Today Sunshine | Beijing, Beijing, China |
Trevi Health Ventures | New York, New York, United States |
Women Business Angels Club | Belgium, Brabant Wallon, Mont-saint-guibert |
Xinjiang Guanghui Chelianwang Touzi Guanli Youxian Gongsi | China, Ürümqi, Xinjiang |
Zuellig Pharma China | China, Guangdong, Wanchai |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.